» Articles » PMID: 30386989

Icariin Ameliorates Angiotensin II-induced Cerebrovascular Remodeling by Inhibiting Nox2-containing NADPH Oxidase Activation

Overview
Journal Hum Cell
Publisher Springer
Specialty Cell Biology
Date 2018 Nov 3
PMID 30386989
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebrovascular smooth muscle cells (SMCs) hyperplasia is an important contributor to cerebrovascular remodeling during hypertension. The aim of present study was to investigate the effects of Icariin on cerebrovascular SMCs proliferation and remodeling and the underlying mechanisms. The results revealed that Icariin administration attenuated the enhanced basilar artery constriction in angiotensin II (AngII)-induced hypertension rat model, as well as the inhibition of basilar artery diameter reduction in response to AngII and phenylephrine. In addition, histological analyses showed that Icariin also significantly ameliorated basilar artery remodeling in AngII hypertensive rats. In human brain vascular SMCs (HBVSMCs), AngII-induced cell proliferation, migration and invasion were markedly inhibited by Icariin treatment. Moreover, Icariin treatment largely limited AngII-induced the increase of reactive oxygen species (ROS) production in HBVSMCs, which was closely associated with cell proliferation. Analysis of the mechanisms showed that Icariin decreased ROS production via inhibiting NADPH oxidase activity but not mitochondria-derived ROS production. Further, Icariin promoted Nox2 degradation and consequently reduced its protein expression. In conclusion, these findings demonstrate that Icariin attenuates cerebrovascular SMCs hyperplasia and subsequent remodeling through inhibiting Nox2-containing NADPH oxidase activation, suggesting Icariin may be a potential therapeutic agent to prevent the onset and progression of stroke.

Citing Articles

Potential effects of icariin, the Epimedium-derived bioactive compound in the treatment of COVID-19: a hypothesis.

Khezri M, Nazari-Khanamiri F, Mohammadi T, Moloodsouri D, Ghasemnejad-Berenji M Naunyn Schmiedebergs Arch Pharmacol. 2022; 395(9):1019-1027.

PMID: 35657423 PMC: 9163523. DOI: 10.1007/s00210-022-02262-y.


Targeting Reactive Oxygen Species in Atherosclerosis via Chinese Herbal Medicines.

Zhang L, Huang J, Zhang D, Lei X, Ma Y, Cao Y Oxid Med Cell Longev. 2022; 2022:1852330.

PMID: 35047104 PMC: 8763505. DOI: 10.1155/2022/1852330.


Characterization of a murine model of endothelial dysfunction induced by chronic intraperitoneal administration of angiotensin II.

Trejo-Moreno C, Jimenez-Ferrer E, Castro-Martinez G, Mendez-Martinez M, Santana M, Arrellin-Rosas G Sci Rep. 2021; 11(1):21193.

PMID: 34707201 PMC: 8551243. DOI: 10.1038/s41598-021-00676-x.


Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review.

Wang S, Ma J, Zeng Y, Zhou G, Wang Y, Zhou W Drug Des Devel Ther. 2021; 15:3619-3641.

PMID: 34447243 PMC: 8384151. DOI: 10.2147/DDDT.S310686.


Role of Polyphenols as Antioxidant Supplementation in Ischemic Stroke.

Zhou Y, Zhang S, Fan X Oxid Med Cell Longev. 2021; 2021:5471347.

PMID: 34257802 PMC: 8253632. DOI: 10.1155/2021/5471347.


References
1.
Ohtsu H, Suzuki H, Nakashima H, Dhobale S, Frank G, Motley E . Angiotensin II signal transduction through small GTP-binding proteins: mechanism and significance in vascular smooth muscle cells. Hypertension. 2006; 48(4):534-40. DOI: 10.1161/01.HYP.0000237975.90870.eb. View

2.
Feihl F, Liaudet L, Waeber B, Levy B . Hypertension: a disease of the microcirculation?. Hypertension. 2006; 48(6):1012-7. DOI: 10.1161/01.HYP.0000249510.20326.72. View

3.
Bedard K, Lardy B, Krause K . NOX family NADPH oxidases: not just in mammals. Biochimie. 2007; 89(9):1107-12. DOI: 10.1016/j.biochi.2007.01.012. View

4.
Forstermann U . Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med. 2008; 5(6):338-49. DOI: 10.1038/ncpcardio1211. View

5.
Feihl F, Liaudet L, Waeber B . The macrocirculation and microcirculation of hypertension. Curr Hypertens Rep. 2009; 11(3):182-9. DOI: 10.1007/s11906-009-0033-6. View